Reckitt Benckiser Group (LON:RB) PT Lowered to GBX 5,550

Share on StockTwits

Reckitt Benckiser Group (LON:RB) had its price objective lowered by Credit Suisse Group from GBX 5,800 ($75.79) to GBX 5,550 ($72.52) in a report published on Friday, November 1st, Borsen Zeitung reports. Credit Suisse Group currently has an underperform rating on the stock.

A number of other research firms have also recently weighed in on RB. DZ Bank cut their price target on Reckitt Benckiser Group from GBX 6,500 ($84.93) to GBX 6,000 ($78.40) and set a hold rating on the stock in a report on Thursday, October 31st. Berenberg Bank cut their price target on Reckitt Benckiser Group from GBX 7,420 ($96.96) to GBX 7,150 ($93.43) and set a buy rating on the stock in a report on Wednesday, October 23rd. Royal Bank of Canada cut their price target on Reckitt Benckiser Group from GBX 5,900 ($77.09) to GBX 5,300 ($69.25) and set an underperform rating on the stock in a report on Wednesday, October 23rd. Liberum Capital reiterated a buy rating and set a GBX 7,300 ($95.39) price objective on shares of Reckitt Benckiser Group in a research note on Thursday, October 31st. Finally, HSBC set a GBX 7,700 ($100.61) price objective on shares of Reckitt Benckiser Group and gave the company a buy rating in a research note on Thursday, October 10th. Four investment analysts have rated the stock with a sell rating, four have assigned a hold rating and ten have issued a buy rating to the company. The company currently has a consensus rating of Hold and a consensus price target of GBX 6,803.89 ($88.90).

LON RB traded down GBX 49 ($0.64) during trading hours on Friday, reaching GBX 5,910 ($77.22). The company’s stock had a trading volume of 716,737 shares, compared to its average volume of 1,720,000. The company has a current ratio of 0.59, a quick ratio of 0.43 and a debt-to-equity ratio of 85.08. The business has a 50-day simple moving average of GBX 6,094.38 and a 200 day simple moving average of GBX 6,236.48. Reckitt Benckiser Group has a 52 week low of GBX 5,510 ($72.00) and a 52 week high of GBX 6,778 ($88.57). The stock has a market cap of $42.03 billion and a PE ratio of 29.67.

In related news, insider Adrian Nevil Hennah sold 81,063 shares of Reckitt Benckiser Group stock in a transaction on Thursday, August 29th. The shares were sold at an average price of GBX 6,399 ($83.61), for a total value of £5,187,221.37 ($6,778,023.48). Also, insider Warren Tucker acquired 580 shares of Reckitt Benckiser Group stock in a transaction that occurred on Friday, October 25th. The stock was acquired at an average cost of GBX 5,810 ($75.92) per share, with a total value of £33,698 ($44,032.41).

About Reckitt Benckiser Group

Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.

See Also: Why do companies engage in swaps?

Analyst Recommendations for Reckitt Benckiser Group (LON:RB)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.